Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Melonfrost
AddedFeb 15, 2024
UpdatedJun 18, 2026
Melonfrost

Melonfrost

Melonfrost: A Brooklyn-based biotech startup innovating in the field of biotechnology.

HQ
New York, US
Founded
2019
Overview
Compare
Fundraising
Employees

Melonfrost is a biotechnology startup based in Brooklyn, New York. The company focuses on innovative solutions within the biotech industry, aiming to advance scientific research and development. Their mission is to leverage cutting-edge technology to address complex biological challenges and improve human health.

Melonfrost has made significant strides in the biotech sector, contributing to advancements in scientific research. Their work has garnered attention and support from various stakeholders in the industry, positioning them as a notable player in the biotech community.

Melonfrost - Similar Companies

MelaTech logo

MelaTech

melatech.space

Selva logo

Selva

Omix.ai logo

Omix.ai

MeliBio logo

MeliBio

melibio.com

Biotechonomy logo

Biotechonomy

Marlinspike Therapeutics logo

Marlinspike Therapeutics

Biotech Holdings logo

Biotech Holdings

Control Panel logo

Control Panel

Orchid BioVentures logo

Orchid BioVentures

Montlake Bioscience logo

Montlake Bioscience

Bioregency logo

Bioregency

Mycelial logo

Mycelial

mycelial.co

GenieBiome logo

GenieBiome

Phylos logo

Phylos

Bioz logo

Bioz

bioz.com

Melonfrost - Quick Facts

Who are Melonfrost's competitors?

Companies similar to Melonfrost include MelaTech, Selva, Omix.ai and MeliBio.

When was Melonfrost founded?

Melonfrost was founded in 2019.

Where is Melonfrost's headquarters located?

Melonfrost's headquarters is located in New York, US.

When was Melonfrost's last funding round?

Melonfrost's most recent funding round was for $7M (USD) in January 2023.

How much has Melonfrost raised to-date?

As of Jan 25, 2023, Melonfrost has raised a total of $7M (USD).

How many employees does Melonfrost have?

Melonfrost has 14 employees as of Feb 4, 2024.

Melonfrost - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Biotechnology
Tags
  • SaaS
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software